Synapse
⌘+K
Synapse
PulseExploreClubsResearchersJournals
Instagram
HomeClubsExplore
July 31, 2012Journal of Clinical Oncology

Neuropathy Is Not Associated With Clinical Outcomes in Patients Receiving Adjuvant Taxane-Containing Therapy for Operable Breast Cancer

View Full Paper
Ask AI
Bookmark
Share

Authors

BSBryan P. SchneiderIndiana University HealthFZFengmin ZhaoEastern Cooperative Oncology GroupMWMolin WangBrigham and Women's Hospital

Discussion

Loading...

Member takes

Implication

Key Points

Key points are not available for this paper at this time.

Cite This Study

Schneider et al. (2012) studied this question.

synapsesocial.com/papers/6a736181ba4be02f5656627bhttps://doi.org/10.1200/jco.2011.39.8446
View Full Paper
Ask AI
Bookmark
Share

Also Consider

Synapse has enriched 2 closely related papers on similar clinical questions. Consider them for comparative context:

  1. 1Benefit of taxanes as adjuvant chemotherapy for early breast cancer2006 · 147 citations
  2. 2Peripheral Neuropathy Induced by Microtubule-Stabilizing Agents2006 · 482 citations